Plain-English translation of NCT05962216 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is observing how works for patients like you who are being treated for psychosis or depression in real-world settings. Instead of testing a brand-new drug in a controlled lab, researchers want to understand how this medication performs when used in regular medical practice. You would be followed for 6 months to see how your symptoms change and how well you tolerate the treatment.
While this medication has been studied in controlled settings, there's a gap in understanding how it actually works for patients in everyday life, with all the complexities of real-world medicine. This research will help doctors learn whether this treatment is truly helpful for people like you managing psychosis or depression outside of clinical trials.
You likely qualify if…
You likely don't qualify if…
You would continue taking your medication as prescribed by your doctor—the study does not change your treatment plan. Over 6 months, researchers would check in with you to track your symptoms, how you're tolerating the medication, and how you're doing overall. The study is designed to fit into your regular care, so there is minimal disruption to your life.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
Hong Kong
Collaborators
Otsuka Pharmaceutical Co., Ltd.
Enrollment target
~40 participants
Started
July 2023
Primary completion
December 2026
Age range
18 Years – 65 Years
Last updated on clinicaltrials.gov in July 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Albert KK Chung, MBBS
Dr. Albert Kar-Kin Chung
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.